Expression of the osteonectin gene potentially controlled by multiple Cis- and trans-acting factors in cultured bone cells
Open Access
- 1 October 1991
- journal article
- research article
- Published by Oxford University Press (OUP) in Journal of Bone and Mineral Research
- Vol. 6 (10) , 1127-1136
- https://doi.org/10.1002/jbmr.5650061015
Abstract
The cis-acting regulatory elements of the osteonectin gene have been studied using a chloramphenicol acetyl-transferase (CAT) promoter assay in osteonectin-expressing and nonexpressing cultured cells. When various stretches of the promoter were transiently transfected into fetal bovine bone cells, a positive element was detected in the DNA located between bases −504 and 11 (1 being the start of transcription) and a negative element between bases −900 and −504. The positive element of the promoter also conferred preferential expression of the gene, showing more activity in cells with higher levels of osteonectin mRNA expression. A 1.2 kb fragment of intron 1 displayed a negative effect on CAT expression when inserted 5′ to the promoter. An additional regulatory element was found in DNA encoding exon 1, which significantly influenced expression of the gene in fetal bovine bone cells. Gel shift analysis using positive genomic elements located 5′ to the start of transcription indicated that one of the nuclear proteins that interacts with the osteonectin promoter may be related to the transcription factor AP2.Keywords
This publication has 47 references indexed in Scilit:
- A downstream initiation element required for efficient TATA box binding and in vitro function of TFIIDNature, 1990
- Transactivation by the hepatitis B virus X protein depends on AP-2 and other transcription factorsNature, 1990
- Structure and Expression of Osteonectin Mrna in Human TissueConnective Tissue Research, 1990
- Structure of human osteonectin based upon analysis of cDNA and genomic sequencesBiochemistry, 1989
- SPARC, a secreted protein associated with cellular proliferation, inhibits cell spreading in vitro and exhibits Ca+2-dependent binding to the extracellular matrix.The Journal of cell biology, 1989
- Molecular analysis of the cDNA for human SPARC/osteonectin/BM-40: Sequence, expression, and localization of the gene to chromosome 5q31-q33Genomics, 1988
- In vivo expression of mRNA for the Ca++-binding protein SPARC (osteonectin) revealed by in situ hybridization.The Journal of cell biology, 1987
- Purification and Biochemical Characterization of the Promoter-Specific Transcription Factor, Sp1Science, 1986
- Endothelial cell injury in vitro is associated with increased secretion of an Mr 43,000 glycoprotein ligandJournal of Cellular Physiology, 1986
- Inhibition of hydroxyapatite-crystal growth by bone-specific and other calcium-binding proteinsBiochemistry, 1986